Skip to main content
Top
Published in: Hepatology International 2/2024

15-09-2023 | Primary Biliary Cholangitis | Original Article

ChIP-seq analysis found IL21R, a target gene of GTF2I–the susceptibility gene for primary biliary cholangitis in Chinese Han

Authors: Ziyan Wu, Haolong Li, Honglin Xu, Futai Feng, Fengchun Zhang, Shulan Zhang, Li Wang, Yongzhe Li

Published in: Hepatology International | Issue 2/2024

Login to get access

Abstract

Aims

Aimed to identify a new susceptibility gene associated with primary biliary cholangitis (PBC) in Chinese Han and investigate the possible mechanism of that gene in PBC.

Methods

A total of 466 PBC and 694 healthy controls (HC) were included in our study, and genotyping GTF2I gene variants by Sequenom. CD19 + B cells were isolated for Chromatin immunoprecipitation sequencing (ChIP-seq). Additionally, MEME-ChIP was utilized to perform searches for known motifs and de novo motif discovery. The GTF2I ChIP-seq of hematopoietic cell line (K562) results were obtained from ENCODE (GSE176987, GSE177691). The Genomic HyperBrowser was used to determine overlap and hierarchal clustering between ours and ENCODE datasets.

Results

The frequency of the rs117026326 variant T allele was significantly higher in PBC patients than that in HC (20.26% compared with 13.89%, Pc = 1.09E-04). Furthermore, we observed an elevated proportion of GTF2I binding site located in the upstream and 5ʹ UTR of genes in PBC in comparison with HC. Additionally, an in-depth analysis of IL21R region revealed that GTF2I might bind to the IL21R promoter to regulate the expression of the IL21R, with four peaks of GTF2I binding sites, including three increased binding sites in upstream, one increased binding site in 5' UTR. Motif analysis by MEME-ChIP uncovered five significant motifs. A significant overlap between our ChIP and GSE176987, GSE17769 were found by the Genomic HyperBroswer.

Conclusions

Our study confirmed that GTF2I was associated with PBC in Chinese Han. Furthermore, our gene function analysis indicated that IL21R may be the target gene regulated by GTF2I.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gulamhusein AF, Hirschfield GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 2020;17(2):93–110CrossRefPubMed Gulamhusein AF, Hirschfield GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 2020;17(2):93–110CrossRefPubMed
2.
go back to reference Liu H, Liu Y, Wang L, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol. 2010;10:100CrossRefPubMedPubMedCentral Liu H, Liu Y, Wang L, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol. 2010;10:100CrossRefPubMedPubMedCentral
3.
go back to reference Zeng N, Duan W, Chen S, et al. Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hepatol Int. 2019;13(6):788–799CrossRefPubMed Zeng N, Duan W, Chen S, et al. Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hepatol Int. 2019;13(6):788–799CrossRefPubMed
4.
go back to reference Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis. 2020;40(1):34–48CrossRefPubMed Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis. 2020;40(1):34–48CrossRefPubMed
5.
go back to reference Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet (London, England). 2011;377(9777):1600–1609CrossRefPubMed Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet (London, England). 2011;377(9777):1600–1609CrossRefPubMed
6.
go back to reference Quarneti C, Muratori P, Lalanne C, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35(2):636–641CrossRefPubMed Quarneti C, Muratori P, Lalanne C, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35(2):636–641CrossRefPubMed
7.
go back to reference Colapietro F, Lleo A, Generali E. Antimitochondrial antibodies: from bench to bedside. Clin Rev Allergy Immunol. 2022;63(2):166–177CrossRefPubMed Colapietro F, Lleo A, Generali E. Antimitochondrial antibodies: from bench to bedside. Clin Rev Allergy Immunol. 2022;63(2):166–177CrossRefPubMed
8.
go back to reference Granito A, Muratori P, Muratori L, et al. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24(11–12):1575–1583CrossRefPubMed Granito A, Muratori P, Muratori L, et al. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24(11–12):1575–1583CrossRefPubMed
9.
go back to reference Granito A, Muratori P, Muratori L, et al. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;26(6):831–838CrossRefPubMed Granito A, Muratori P, Muratori L, et al. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;26(6):831–838CrossRefPubMed
10.
go back to reference Nakamura M, Nishida N, Kawashima M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet. 2012;91(4):721–728CrossRefPubMedPubMedCentral Nakamura M, Nishida N, Kawashima M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet. 2012;91(4):721–728CrossRefPubMedPubMedCentral
11.
go back to reference Cordell HJ, Han Y, Mells GF, et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun. 2015;6:8019CrossRefPubMed Cordell HJ, Han Y, Mells GF, et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun. 2015;6:8019CrossRefPubMed
12.
go back to reference Sun C, Molineros JE, Looger LL, et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet. 2016;48(3):323–330CrossRefPubMedPubMedCentral Sun C, Molineros JE, Looger LL, et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet. 2016;48(3):323–330CrossRefPubMedPubMedCentral
13.
go back to reference Kawashima M, Hitomi Y, Aiba Y, et al. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet. 2017;26(3):650–659PubMed Kawashima M, Hitomi Y, Aiba Y, et al. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population. Hum Mol Genet. 2017;26(3):650–659PubMed
14.
15.
go back to reference Wang C, Zheng X, Jiang P, et al. Genome-wide association studies of specific antinuclear autoantibody subphenotypes in primary biliary cholangitis. Hepatology. 2019;70(1):294–307CrossRefPubMed Wang C, Zheng X, Jiang P, et al. Genome-wide association studies of specific antinuclear autoantibody subphenotypes in primary biliary cholangitis. Hepatology. 2019;70(1):294–307CrossRefPubMed
16.
18.
go back to reference Li Y, Zhang K, Chen H, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren’s syndrome at 7q11.23. Nat Genet. 2013;45(11):1361–1365CrossRefPubMed Li Y, Zhang K, Chen H, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren’s syndrome at 7q11.23. Nat Genet. 2013;45(11):1361–1365CrossRefPubMed
19.
go back to reference Liu C, Yan S, Chen H, et al. Association of GTF2I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a CHinese Han population. Front Immunol. 2021;12: 640083CrossRefPubMedPubMedCentral Liu C, Yan S, Chen H, et al. Association of GTF2I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a CHinese Han population. Front Immunol. 2021;12: 640083CrossRefPubMedPubMedCentral
20.
go back to reference Li Y, Li P, Chen S, et al. Association of GTF2I and GTF2IRD1 polymorphisms with systemic lupus erythematosus in a Chinese Han population. Clin Exp Rheumatol. 2015;33(5):632–638PubMed Li Y, Li P, Chen S, et al. Association of GTF2I and GTF2IRD1 polymorphisms with systemic lupus erythematosus in a Chinese Han population. Clin Exp Rheumatol. 2015;33(5):632–638PubMed
21.
go back to reference Zhao J, Ma J, Deng Y, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49(3):433–437CrossRefPubMedPubMedCentral Zhao J, Ma J, Deng Y, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49(3):433–437CrossRefPubMedPubMedCentral
22.
go back to reference Kim K, Bang SY, Ikari K, et al. Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis. Sci Rep. 2016;6:27563CrossRefPubMedPubMedCentral Kim K, Bang SY, Ikari K, et al. Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis. Sci Rep. 2016;6:27563CrossRefPubMedPubMedCentral
23.
go back to reference Yokoyama N, Kawasaki A, Matsushita T, et al. Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population. Sci Rep. 2019;9(1):16366CrossRefPubMedPubMedCentral Yokoyama N, Kawasaki A, Matsushita T, et al. Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population. Sci Rep. 2019;9(1):16366CrossRefPubMedPubMedCentral
24.
go back to reference Wang L, Zhang FC, Chen H, et al. Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol. 2013;19(31):5131–5137CrossRefPubMedPubMedCentral Wang L, Zhang FC, Chen H, et al. Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol. 2013;19(31):5131–5137CrossRefPubMedPubMedCentral
25.
go back to reference Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines. Hepatology. 2000;31(4):1005–1013CrossRefPubMed Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines. Hepatology. 2000;31(4):1005–1013CrossRefPubMed
26.
go back to reference Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50(1):291–308CrossRefPubMed Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50(1):291–308CrossRefPubMed
27.
go back to reference Abascal F, Acosta R, Addleman NJ, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583(7818):699–710CrossRef Abascal F, Acosta R, Addleman NJ, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583(7818):699–710CrossRef
28.
go back to reference Sandve GK, Gundersen S, Johansen M, et al. The genomic HyperBrowser: an analysis web server for genome-scale data. Nucleic Acids Res. 2013;41(W1):W133–W141CrossRefPubMedPubMedCentral Sandve GK, Gundersen S, Johansen M, et al. The genomic HyperBrowser: an analysis web server for genome-scale data. Nucleic Acids Res. 2013;41(W1):W133–W141CrossRefPubMedPubMedCentral
29.
go back to reference Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012CrossRefPubMed Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012CrossRefPubMed
30.
go back to reference Rajaiya J, Nixon JC, Ayers N, Desgranges ZP, Roy AL, Webb CF. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I. Mol Cell Biol. 2006;26(12):4758–4768CrossRefPubMedPubMedCentral Rajaiya J, Nixon JC, Ayers N, Desgranges ZP, Roy AL, Webb CF. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I. Mol Cell Biol. 2006;26(12):4758–4768CrossRefPubMedPubMedCentral
31.
go back to reference Mehta DS, Wurster AL, Grusby MJ. Biology of IL-21 and the IL-21 receptor. Immunol Rev. 2004;202:84–95CrossRefPubMed Mehta DS, Wurster AL, Grusby MJ. Biology of IL-21 and the IL-21 receptor. Immunol Rev. 2004;202:84–95CrossRefPubMed
32.
go back to reference Long D, Chen Y, Wu H, Zhao M, Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1–14CrossRefPubMed Long D, Chen Y, Wu H, Zhao M, Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1–14CrossRefPubMed
34.
go back to reference Wang L, Sun Y, Zhang Z, et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (Baltimore, MD). 2015;61(2):627–638CrossRefPubMed Wang L, Sun Y, Zhang Z, et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (Baltimore, MD). 2015;61(2):627–638CrossRefPubMed
35.
go back to reference Li Y, Wang W, Tang L, et al. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis. Hepatology (Baltimore, MD). 2015;61(6):1998–2007CrossRefPubMed Li Y, Wang W, Tang L, et al. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis. Hepatology (Baltimore, MD). 2015;61(6):1998–2007CrossRefPubMed
Metadata
Title
ChIP-seq analysis found IL21R, a target gene of GTF2I–the susceptibility gene for primary biliary cholangitis in Chinese Han
Authors
Ziyan Wu
Haolong Li
Honglin Xu
Futai Feng
Fengchun Zhang
Shulan Zhang
Li Wang
Yongzhe Li
Publication date
15-09-2023
Publisher
Springer India
Published in
Hepatology International / Issue 2/2024
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-023-10586-x

Other articles of this Issue 2/2024

Hepatology International 2/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.